BG101338A - Dna encoding human papillomavirus type 6a - Google Patents

Dna encoding human papillomavirus type 6a

Info

Publication number
BG101338A
BG101338A BG101338A BG10133897A BG101338A BG 101338 A BG101338 A BG 101338A BG 101338 A BG101338 A BG 101338A BG 10133897 A BG10133897 A BG 10133897A BG 101338 A BG101338 A BG 101338A
Authority
BG
Bulgaria
Prior art keywords
human papillomavirus
papillomavirus type
dna encoding
encoding human
type
Prior art date
Application number
BG101338A
Other languages
Bulgarian (bg)
English (en)
Inventor
Kathrin Jansen
Kathryn HOFMANN
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23202654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG101338(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of BG101338A publication Critical patent/BG101338A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BG101338A 1994-09-22 1997-03-18 Dna encoding human papillomavirus type 6a BG101338A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31046894A 1994-09-22 1994-09-22
PCT/US1995/011859 WO1996009375A1 (en) 1994-09-22 1995-09-18 Dna encoding human papillomavirus type 6a

Publications (1)

Publication Number Publication Date
BG101338A true BG101338A (en) 1997-10-31

Family

ID=23202654

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101338A BG101338A (en) 1994-09-22 1997-03-18 Dna encoding human papillomavirus type 6a

Country Status (16)

Country Link
US (1) US6290965B1 (fi)
EP (1) EP0782615A4 (fi)
JP (1) JPH10506014A (fi)
AU (1) AU694269B2 (fi)
BG (1) BG101338A (fi)
BR (1) BR9509076A (fi)
CA (1) CA2200582C (fi)
CZ (1) CZ87597A3 (fi)
FI (1) FI121507B (fi)
HU (1) HUT77337A (fi)
NO (1) NO971347L (fi)
NZ (1) NZ293461A (fi)
PL (1) PL319294A1 (fi)
RU (1) RU2177999C2 (fi)
SK (1) SK35897A3 (fi)
WO (1) WO1996009375A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962981B1 (en) * 1996-03-25 2005-11-08 Medarex, Inc. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
PL347472A1 (en) * 1998-08-14 2002-04-08 Merck & Co Inc Process for purifying human papillomavirus virus-like particles
CN1100835C (zh) * 1998-10-30 2003-02-05 中国科学院感光化学研究所 加入纳米无机化合物粒子的钛溶胶－凝胶涂料及其制法和用途
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
WO2004081178A2 (en) * 2003-03-06 2004-09-23 Indiana University Research And Technology Corporation Methods and composition for producing infectious hpv stocks
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
US20080160040A1 (en) * 2004-04-15 2008-07-03 Ghim Shin-Je Plant-produced compositions for treating papillomavirus infection and related methods
US20090053261A1 (en) * 2005-09-08 2009-02-26 Lindbo John A Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
EP1819835B1 (en) 2004-12-08 2010-08-04 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
US8084207B2 (en) * 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US20070031826A1 (en) * 2005-08-05 2007-02-08 My Gene Diagnostic kit for determining the genotype of a human papilloma virus and method of using thereof
KR100904844B1 (ko) * 2006-08-28 2009-06-25 성균관대학교산학협력단 인유두종 바이러스（ｈｐｖ）유전자를 포함하는자궁경부암의 치료 또는 예방용 ｄｎａ 백신
AU2008339985C1 (en) 2007-12-21 2012-12-20 Novartis Ag Mammalian expression vector
JP6153866B2 (ja) 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000152A1 (en) * 1992-06-25 1994-01-06 Georgetown University Papillomavirus vaccines
WO1995031532A1 (en) * 1994-05-16 1995-11-23 Merck & Co., Inc. Papillomavirus vaccines
AR004464A1 (es) * 1994-11-14 1998-12-16 Merck Sharp & Dohme Un metodo para producir una proteina de capside de papilomavirus
IL117591A0 (en) * 1995-03-30 1996-07-23 Merck & Co Inc Synthetic DNA encoding human papillomavirus type 11 L1 protein

Also Published As

Publication number Publication date
WO1996009375A1 (en) 1996-03-28
NZ293461A (en) 1998-04-27
AU3591895A (en) 1996-04-09
EP0782615A1 (en) 1997-07-09
FI971203A (fi) 1997-03-21
CA2200582A1 (en) 1996-03-28
CA2200582C (en) 2007-03-27
BR9509076A (pt) 1998-07-14
NO971347L (no) 1997-05-21
NO971347D0 (no) 1997-03-21
PL319294A1 (en) 1997-08-04
HUT77337A (hu) 1998-03-30
MX9702209A (es) 1997-07-31
EP0782615A4 (en) 2001-08-22
CZ87597A3 (cs) 1998-01-14
FI971203A0 (fi) 1997-03-21
JPH10506014A (ja) 1998-06-16
RU2177999C2 (ru) 2002-01-10
AU694269B2 (en) 1998-07-16
SK35897A3 (en) 1998-02-04
US6290965B1 (en) 2001-09-18
FI121507B (fi) 2010-12-15

Similar Documents

Publication Publication Date Title
WO1996030520A3 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
ZA962245B (en) Dna encoding human papillomavirus type 18
BG101338A (en) Dna encoding human papillomavirus type 6a
ZA961511B (en) Byproduct stream purification in the preparation of 1,3-propanediol-based polyesters
CA2215834A1 (en) Dna encoding human papillomavirus type 18
EP0683676A4 (en) BIODISTRIBUTION DIRECTED FROM SMALL MOLECULES.
BG102818A (en) D-manitol and method for its preparation
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
SG69985A1 (en) The process of asphalt purification and the composition of modified asphalt
AU4361696A (en) New uses of indolo-{2,3b}-quinoxalines
BR9706702A (pt) Purificação de 1,1,1,3,3-pentafluorpropano
HRP970224A2 (en) TREATMENT OF ASTHMA WITH TNFR-Ig
IL124415A0 (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
PL343758A1 (en) Purification of carboxaldehyde
AU5425098A (en) Compounds and methods to treat infectious diseases
PL321001A1 (en) Monomers of 4,4-disubstituted cyclohexan-1-one and compounds showing affinity to them
GB9214449D0 (en) Purification of 1,1,1,2-tetrafluoroethane
PL321000A1 (en) 3,3-(disubstituted) monomers of cyclohexan-1-ol and compounds showing affinity to them
EP0912595A4 (en) MOLECULES ASSOCIATED WITH HODGKIN'S DISEASE AND USES THEREOF
AU1587295A (en) The treatment of gaseous substances
IL123526A0 (en) Gas burner of the type known as "living-flame"
DE69534740D1 (en) Analoge des thymosin alpha 1
GB9606851D0 (en) Improvements relating to the manufacture of sleeper rings
PL320957A1 (en) 3,3-(disubstuted) monomers of cyclohexan-1-on and compounds showing affinity to them
GB9508521D0 (en) Improvements relating to the coding of products